hylabs (Hy Laboratories Ltd)
Doron Cohen has extensive experience in leadership roles, currently serving as President of Hy Laboratories Ltd since March 2021 and previously as CEO of the same company from July 2000 to June 2022. Cohen's career also includes a position as Marketing Manager at Pazgas from June 1997 to July 2000 and Manager at Arkal Filtration Systems from June 1993 to June 1997. Academically, Cohen earned a Master's Degree in Environmental Studies and a Bachelor's Degree in Agriculture from The Hebrew University of Jerusalem.
Previous companies
This person is not in any teams
This person is not in any offices
hylabs (Hy Laboratories Ltd)
hylabs is the leading diagnostic company in Israel in the field of microbiology specially in infection diseases. For five decades, it has specialized in the development, production and marketing of services and products for the detection and identification of microorganisms. Today the company leads the field through advanced molecular methods such as RTPCR and NGS (Next Generation Sequencing) or the clinical, industrial, research and innovation markets, alongside the continued production of classical tools for conventional culturing methods. Expertise The products and services offered to the company's customers together with the extensive knowledge and proficiency of our staff are designed to help our customers meet the highest requirements of international and local standards. Our R&D TEAM works closely with leading experts in the field of microbiology and molecular biology, develops and practices the world's most advanced technologies accessible to the market. An internal quality assurance unit oversees all testing performed in laboratories to ensure the accuracy and reliability of the results. The company operates professional customer service and support teams that provide technical assistance both remotely and at the customer's site.